| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | Director | Common Stock | 25,940 | $985,201 | $37.98 | 15 May 2025 | Direct |
| Alector, Inc. | President and COO | Common Stock | 102,598 | $570,445 | $5.56 | 13 Dec 2021 | Direct |
| 10x Genomics, Inc. | Director | Class A Common Stock | 28,616 | $271,565 | $9.49 | 03 Jun 2025 | Direct |
| Alector, Inc. | President and COO | Employee Stock Option (right to buy) | 305,187 | 13 Dec 2021 | Direct | ||
| Ultragenyx Pharmaceutical Inc. | Director | Stock Option (Right to Buy) | 10,787 | 15 May 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| TXG | 10x Genomics, Inc. | 03 Jun 2025 | 1 | $0 | 4 | Director | 05 Jun 2025, 17:22 |
| RARE | Ultragenyx Pharmaceutical Inc. | 15 May 2025 | 2 | $0 | 4 | Director | 19 May 2025, 18:34 |
| RARE | Ultragenyx Pharmaceutical Inc. | 18 Jun 2024 | 2 | $0 | 4 | Director | 20 Jun 2024, 14:22 |
| TXG | 10x Genomics, Inc. | 11 Jun 2024 | 1 | $0 | 4 | Director | 13 Jun 2024, 16:23 |
| TXG | 10x Genomics, Inc. | 14 Jun 2023 | 2 | $0 | 4 | Director | 16 Jun 2023, 17:43 |
| RARE | Ultragenyx Pharmaceutical Inc. | 07 Jun 2023 | 2 | $0 | 4 | Director | 09 Jun 2023, 14:30 |
| RARE | Ultragenyx Pharmaceutical Inc. | 24 Jun 2022 | 2 | $0 | 4 | Director | 28 Jun 2022, 13:48 |
| TXG | 10x Genomics, Inc. | 15 Jun 2022 | 2 | $0 | 4 | Director | 17 Jun 2022, 17:16 |
| ALEC | Alector, Inc. | 10 Dec 2021 | 8 | -$640,816 | 4 | President and COO | 14 Dec 2021, 19:23 |
| ALEC | Alector, Inc. | 08 Dec 2021 | 10 | -$1,222,416 | 4 | President and COO | 10 Dec 2021, 18:20 |
| RARE | Ultragenyx Pharmaceutical Inc. | 24 Jun 2021 | 2 | $0 | 4 | Director | 28 Jun 2021, 18:22 |
| TXG | 10x Genomics, Inc. | 11 Jun 2021 | 2 | $0 | 4 | Director | 15 Jun 2021, 17:54 |
| ALEC | Alector, Inc. | 07 May 2021 | 1 | $0 | 4 | President and COO | 11 May 2021, 18:34 |